Sort   by:  
 Page size 
UnknownPhase III randomized clinical trial comparing tremelimumab with standard-of-care chemotherapy in patients with advanced melanoma.
Not available
S-EPMC4878048 | biostudies-literature
UnknownA First-Time-In-Human Phase I Clinical Trial of Bispecific Antibody-Targeted, Paclitaxel-Packaged Bacterial Minicells.
Not available
S-EPMC4699457 | biostudies-literature
UnknownCombined systems approaches reveal highly plastic responses to antimicrobial peptide challenge in Escherichia coli.
Not available
S-EPMC4006907 | biostudies-literature
UnknownImmune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment.
Not available
S-EPMC7594513 | biostudies-literature
UnknownWhole exome sequencing identifies a recurrent RQCD1 P131L mutation in cutaneous melanoma.
Not available
S-EPMC4359221 | biostudies-literature
UnknownCX-5461 Preferentially Induces Top2α-Dependent DNA Breaks at Ribosomal DNA Loci.
Not available
S-EPMC11275095 | biostudies-literature
UnknownTargeted-capture massively-parallel sequencing enables robust detection of clinically informative mutations from formalin-fixed tumours.
Not available
S-EPMC3861801 | biostudies-literature
UnknownTULIP: a randomised controlled trial of surgical versus non-surgical treatment of lateral compression injuries of the pelvis with complete sacral fractures (LC1) in the non-fragility fracture patient-a feasibility study protocol.
Not available
S-EPMC7044852 | biostudies-literature
UnknownChanges in long-range rDNA-genomic interactions associate with altered RNA polymerase II gene programs during malignant transformation.
Not available
S-EPMC6349880 | biostudies-literature
UnknownInhibition of RNA polymerase I transcription initiation by CX-5461 activates non-canonical ATM/ATR signaling.
Not available
S-EPMC5226549 | biostudies-literature
Sort   by:  
 Page size